Mrs Paula Ann Cobb, RPT | |
119 Main St, Carbondale, KS 66414-9628 | |
(785) 836-7500 | |
(785) 836-7500 |
Full Name | Mrs Paula Ann Cobb |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 119 Main St, Carbondale, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265637813 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 11-02355 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Paula Ann Cobb, RPT Po Box 329, 119 Main Street, Carbondale, KS 66414 Ph: (785) 836-7500 | Mrs Paula Ann Cobb, RPT 119 Main St, Carbondale, KS 66414-9628 Ph: (785) 836-7500 |
News Archive
The natural DNA bases that form the letters of DNA are usually referred to as G, C, A, and T. Those are only the first letters of the chemical names. They're often called nucleotides by their scientific name and all of them have in common a phosphate part, a sugar part and a nucleobase part.
Palliative care, a specialized, multidisciplinary team approach to caring for seriously ill people and their families, is often errantly reduced to end-of-life care. This misconception has led to palliative care involvement being introduced late in an illness, often depriving patients and their families of comprehensive symptom control, support and assistance with complex decision-making throughout the course of their illness when it could provide the most benefit.
Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.
Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical laboratories from 22 countries and European institutions that develop in vitro molecular diagnostic assays in oncology, genetic disease and infectious disease will now be able to leverage the instrument's regulatory clearance to develop tests for clinical applications.
› Verified 8 days ago